Mechanistic Studies on Hsp90 Inhibition by Ansamycin Derivatives
- 29 June 2007
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 372 (2) , 287-297
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Molecular chaperones and protein kinase quality controlTrends in Cell Biology, 2007
- Chaperoning steroid hormone actionTrends in Endocrinology & Metabolism, 2006
- Inhibitors of the HSP90 Molecular Chaperone: Attacking the Master Regulator in CancerCurrent Topics in Medicinal Chemistry, 2006
- Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in CancerCurrent Topics in Medicinal Chemistry, 2006
- Inhibitors of the HSP90 Molecular Chaperone: Current Status2006
- Pharmacokinetic-Pharmacodynamic Relationships for the Heat Shock Protein 90 Molecular Chaperone Inhibitor 17-Allylamino, 17-Demethoxygeldanamycin in Human Ovarian Cancer Xenograft ModelsClinical Cancer Research, 2005
- HSP90 and the chaperoning of cancerNature Reviews Cancer, 2005
- Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma modelsCancer Chemotherapy and Pharmacology, 2005
- Structural Basis for Inhibition of the Hsp90 Molecular Chaperone by the Antitumor Antibiotics Radicicol and GeldanamycinJournal of Medicinal Chemistry, 1999
- ATP binding and hydrolysis are essential to the function of the Hsp90 molecular chaperone in vivoThe EMBO Journal, 1998